Showing 1 - 20 results of 21 for search 'P Sonneveld', query time: 0.05s
Refine Results
-
1
COVID-19 AND MYELOMA by H Ludwig, P Sonneveld, M Boccadoro, E Terpos, European Multiple Myeloma Network (EMN)
Published 2022-04-01
Article -
2
P38 PATIENT-REPORTED OUTCOMES (PRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH MELFLUFEN AND DEXAMETHASONE (DEX) OR POMALIDOMIDE (POM) AND DEX: ANALYSES FROM THE P... by F Schjesvold, H Ludwig, S Delimpasi, P Robak, M Mateos, A Sandberg, M Thuresson, S Norin, P Richardson, P Sonneveld
Published 2023-05-01
Article -
3
P915: EFFICACY AND SAFETY OF DARATUMUMAB MONOTHERAPY IN NEWLY DIAGNOSED PATIENTS WITH STAGE 3B LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK by E. Kastritis, M. C. Minnema, M. A. Dimopoulos, G. Merlini, F. Theodorakakou, D. Fotiou, A. Huart, K. Belhadj, S. Gkolfinopoulos, K. Manousou, P. Sonneveld, G. Palladini
Published 2022-06-01
Article -
4
P914: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK by E. Kastritis, G. Palladini, M. A. Dimopoulos, A. Jaccard, G. Merlini, F. Theodorakakou, D. Fotiou, M. C. Minnema, A. Wechalekar, S. Gkolfinopoulos, K. Manousou, P. Sonneveld, S. Schönland
Published 2022-06-01
Article -
5
-
6
B07 HIGH EXPRESSION OF NUCLEAR CEREBLON IS ASSOCIATED WITH LONGER SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH IMIDS by R. Wester, M. van Duin, K.H. Lam, S.S. Couto, Y. Ren, M. Wang, T. Cupedo, B. van der Holt, H.B. Beverloo, A.L. Nigg, A. Thakurta, A.A. Waage, S. Zweegman, A. Broijl, P. Sonneveld
Published 2023-05-01
Article -
7
POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE AFTER 1 PRIOR LINE OF THERAPY IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBANALYSIS OF OPTIMMISM BY AGE, PRIOR TRANSPLANT, AND HIGH-RISK C... by M. Dimopoulos, K. Weisel, P. Moreau, L.D.A. Jr, D. White, J.S. Miguel, P. Sonneveld, M. Engelhardt, M. Jenner, A. Corso, J. Dürig, M. Pavic, M. Salomo, E. Casal, R. Jiang, T. Nguyen, T. Peluso, P. Richardson
Published 2020-11-01
Article -
8
P933: DARATUMUMAB (D) IN COMBINATION WITH VD OR D-RD IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF CASTOR AND POLLUX STUDIES IN PATIENTS WITH EARLY OR LATE RELAP... by A. Spencer, P. Moreau, M.-V. Mateos, H. Goldschmidt, K. Suzuki, M.-D. Levin, P. Sonneveld, S.-S. Yoon, S. Z. Usmani, K. Weisel, D. Reece, T. Ahmadi, H. Pei, W. Garvin Mayo, X. Gai, J. Carey, R. Carson, M. A. Dimopoulos
Published 2022-06-01
Article -
9
P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE... by P Sonneveld, A Chanan-Khan, K Weisel, AK Nooka, T Masszi, M Beksac, I Spicka, V Hungria, M Munder, MV Mateos, TM Mark, MD Levin, T Ahmadi, X Qin, W Garvin Mayo, X Gai, J Carey, R Carson, A Spencer
Published 2022-04-01
Article -
10
B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND E... by NWCJ van de Donk, M Delforge, M Agha, AD Cohen, YC Cohen, J Hillengass, S Anguille, T Kerre, W Roeloffzen, JM Schecter, KC De Braganca, H Varsos, L Wang, M Vogel, E Zudaire, C Corsale, M Akram, D Geng, T Nesheiwat, L Pacaud, P Sonneveld, S Zweegman
Published 2022-04-01
Article -
11
S185: CARTITUDE-2 COHORT B: UPDATED CLINICAL DATA AND BIOLOGICAL CORRELATIVE ANALYSES OF CILTACABTAGENE AUTOLEUCEL IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL... by M. E. Agha, N. W. van de Donk, A. D. Cohen, Y. C. Cohen, S. Anguille, T. Kerre, W. Roeloffzen, J. M. Schecter, K. C. De Braganca, H. Varsos, P. Mistry, T. Roccia, E. Zudaire, C. Corsale, M. Akram, D. Geng, T Nesheiwat, L. Pacaud, P. Sonneveld, S. Zweegman
Published 2022-06-01
Article -
12
P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PAT... by A. Broijl, J. San-Miguel, K. Suzuki, A. Krishnan, N. van de Donk, G. Cook, A. Jakubowiak, D. Madduri, S. Afifi, A. Stevens, J. Schecter, W. Deraedt, S. Kuppens, P. Mistry, L. Pacaud, M. Boccadoro, F. Gay, R. Mina, L. Rasche, P. Moreau, M. Mateos, H. Einsele, P. Sonneveld
Published 2023-05-01
Article -
13
B05 PLASMA CELL LEUKEMIA-LIKE STATUS HAS INDEPENDENT PROGNOSTIC VALUE IN THE CONTEXT OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM by D. Hofste op Bruinink, R. Kuiper, M. van Duin, T. Cupedo, V. van der Velden, R. Hoogenboezem, B. van der Holt, B. Beverloo, E. Valent, M. Vermeulen, M. D’Agostino, F. Gay, A. Broijl, H. Avet-Loiseau, N. Munshi, P. Musto, P. Moreau, S. Zweegman, N. van de Donk, P. Sonneveld
Published 2023-05-01
Article -
14
P1714: HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS IN EUROPE by A. Jaccard, F. Bridoux, W. Roeloffzen, M. C. Minnema, R. Bergantim, R. Hájek, C. João, M. T. Cibeira, G. Palladini, S. Schönland, G. Merlini, P. Milani, M. A. Dimopoulos, S. Ravichandran, U. Hegenbart, H. Agis, B. Gros, A. Asra, E. Dergarabetian, V. Magarotto, A. Leonidakis, G. Cheliotis, P. Sonneveld, A. Wechalekar, E. Kastritis
Published 2022-06-01
Article -
15
B09 CARTITUDE-2 COHORT B 18-MONTH FOLLOW-UP: CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH MULTIPLE MYELOMA (MM) AND EARLY RELAPSE AFT... by S. Zweegman, M. Agha, A.D. Cohen, Y.C. Cohen, S. Anguille, T. Kerre, W. Roeloffzen, D. Madduri, J.M. Schecter, K.C. De Braganca, C.C. Jackson, H. Varsos, P. Mistry, T. Roccia, X. Xu, K. Li, E. Zudaire, C. Corsale, M. Akram, D. Geng, L. Pacaud, P. Sonneveld, N. van de Donk
Published 2023-05-01
Article -
16
B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS by P. Musto, M.C. Minnema, W.W.H. Roeloffzen, A. Capra, B. van der Holt, A. Juul Vangsted, A. Broyl, F. Schjesvold, T. Lund, T. Silkjaer, R. Benjamin, M. Grasso, K. Lung Wu, J. Caers, M. Cavo, R. Hájek, B. Bruno, A. Gadisseur, G. Pietrantuono, M. Offidani, L. Pour, P. Sonneveld, M. Boccadoro, N. van de Donk
Published 2023-05-01
Article -
17
P13 IXAZOMIB, DARATUMUMAB AND LOW-DOSE DEXAMETHASONE IN INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE P... by K. Groen, C. Stege, K. Nasserinejad, K. de Heer, R. van Kampen, R. Leys, N. Thielen, M. Westerman, K. Wu, I. Ludwig, D. Issa, G. Velders, M. Vekemans, N. van de Donk, G. Timmers, F. de Boer, L. Tick, E. van der Spek, E. de Waal, M. Sohne, P. Sonneveld, I. Nijhof, S. Klein, M. Levin, P. Ypma, S. Zweegman
Published 2023-05-01
Article -
18
B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR... by N. van de Donk, M.C. Minnema, B. van der Holt, F. Schjesvold, K.L. Wu, A. Capra, A. Broyl, W.W.H. Roeloffzen, A.P.A. Gadisseur, G. Pietrantuono, L. Pour, V. van der Velden, T. Lund, M. Offidani, M. Grasso, L. Giaccone, M. Cavo, T. Silkjaer, J. Caers, S. Zweegman, R. Hajek, R. Benjamin, A. Vangsted, M. Boccadoro, F. Gay, P. Sonneveld, P. Musto
Published 2023-05-01
Article -
19
P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESUL... by K. Groen, M. R. Seefat, B. van der Holt, F. H. Schjesvold, C. A. Stege, M.-D. Levin, M. Hansson, R. B. Leys, J. Regelink, A. Waage, D. Szatkowski, P. Axelsson, T. H. Do, A. Svirskaite, E. van der Spek, E. Haukas, D. Knut-Bojanowska, P. F. Ypma, C. Blimark, U.-H. Mellqvist, N. W. van de Donk, P. Sonneveld, A. Klostergaard, A. J. Vangsted, N. Abdilgaard, S. Zweegman
Published 2022-06-01
Article -
20
P906: IXAZOMIB, DARATUMUMAB AND LOW DOSE DEXAMETHASONE IN FRAIL PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): RESULTS OF THE MAINTENANCE TREATMENT OF THE PHASE II HOVON 14... by K. Groen, M. Seefat, K. Nasserinejad, C. A. Stege, E. van der Spek, Y. M. Bilgin, A. Kentos, M. Sohne, R. J. van Kampen, I. Ludwig, N. Thielen, N. Durdu-Rayman, N. C. de Graauw, N. W. van de Donk, E. G. de Waal, M.-C. Vekemans, G. J. Timmers, M. van der Klift, S. Soechit, P. A. Geerts, M. H. Silbermann, M. Oosterveld, I. Nijhof, P. Sonneveld, S. K. Klein, M.-D. Levin, S. Zweegman
Published 2022-06-01
Article